Retrospective Study
Copyright ©The Author(s) 2024.
World J Clin Cases. Jun 16, 2024; 12(17): 2995-3003
Published online Jun 16, 2024. doi: 10.12998/wjcc.v12.i17.2995
Table 3 Degree of variability of dosimetric parameters in patients
VariableG0
≥ G2

Mean
Range
Std Dev
Mean
Range
Std Dev
Total volume8.59(6.01-11.75)1.288.90(6.65-11.19)1.40
Dmax39.60(34.35-46.38)3.2442.78(39.40-46.81)2.69
Dmean16.11(10.5-25.28)3.0219.44(14.30-22.49)2.71
RV V10 (%)59.35(28.83-87.50)16.4166.45(37.87-95.19)17.45
RV V20 (%)37.62(19.45-71.20)10.0945.27(31.06-54.15)7.26
RV V30 (%)16.45(5.10-38.69)8.8136.45(26.28-44.83)5.81
RV V35 (%)4.59(0.00-27.09)5.9317.11(7.01-27.95)7.91
RV V40 (%)0.58(0.00-9.57)1.573.02(0.00-11.55)4.36
AV V10 (mL)5.10(2.34-8.97)1.485.73(3.54-7.34)1.34
AV V20 (mL)3.23(1.42-6.55)0.964.03(2.51-5.48)0.91
AV V30 (mL)1.39(0.08-2.79)0.713.25(2.01-4.73)1.34
AV V35 (mL)0.37(0.00-2.03)0.471.49(0.61-2.33)0.67
AV V40 (mL)0.05(0.00-0.88)0.140.27(0.00-1.03)0.40